Prothena | PRTA - El Costo De Ventas

Precio De Mercado
8.75
Cambio Diario
0.21 2.46%
Mensual
-3.53%
Anual
-32.54%
Q1 Expectativa
8.93




El Costo De Ventas Cambio Fecha
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Akebia Therapeutics USD 10.34M 441K 2025-12
ALKERMES USD 46.21M 5.38M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Exelixis USD 26.48M 7.91M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Prothena USD 28.94M 11.58M 2025-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12
Xoma 116K 112.7K 2024-06